SINGAPORE – An artificial intelligence tool that can predict fracture risk in seconds and wearable sensors for fall risk assessment are among the solutions being developed under a new $37.9 million programme to help Singaporeans age more healthily with technology.
Musculoskeletal health and mobility is one of three focus areas under the Future Health Technologies 2 (FHT2) programme.
Beyond assessing fracture and fall risks, the projects also involve the use of bone organoids – lab-grown tissue cultures derived from stem cells – to predict drug responses in patients. This will enable doctors to optimise fracture prevention strategies for those at higher risk.
Musculoskeletal conditions are among the most overlooked health challenges of our time, said National Research Foundation (NRF) chief executive John Lim at the launch of the initiative on March 28.
This is despite such conditions being the leading cause of disability worldwide, affecting more than 1.7 billion globally, he noted.
“Research and innovation are critical to gaining new insights and advancing our understanding of musculoskeletal health,” said Mr Lim.
“The FHT2 programme aims to translate promising AI and robotics research outcomes across musculoskeletal health, mental well-being and rehabilitation into clinical workflows by 2030, while also shifting care upstream from treatment to early detection, prevention and functional recovery in the community.”
The programme is an effort by the Singapore-ETH Centre, a collaboration between the NRF and the Swiss university ETH Zurich.
The second focus area is mental well-being and cognitive health.





